Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ABSI NASDAQ:NRC NASDAQ:RSSS NYSE:TRAK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABSIAbsci$3.12+8.3%$2.78$2.01▼$6.33$397.98M2.013.01 million shs8.71 million shsNRCNational Research$14.22-4.9%$15.30$9.76▼$27.07$324M0.4589,789 shs77,099 shsRSSSResearch Solutions$2.70$2.85$2.32▼$4.24$87.64M0.6784,959 shs30,025 shsTRAKReposiTrak$18.45-1.3%$20.43$15.72▼$25.01$336.28M0.5168,128 shs43,572 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABSIAbsci0.00%+16.85%+13.45%+0.97%-28.77%NRCNational Research0.00%-10.90%-15.51%+34.91%-42.12%RSSSResearch Solutions0.00%-8.16%-3.23%-3.57%+3.85%TRAKReposiTrak0.00%-3.25%-9.16%+1,844,999,900.00%+1,844,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABSIAbsci1.7515 of 5 stars3.51.00.00.01.11.70.6NRCNational Research2.4839 of 5 stars0.04.01.70.01.82.51.3RSSSResearch Solutions1.208 of 5 stars0.03.00.00.01.60.81.9TRAKReposiTrak0.1808 of 5 stars0.00.00.80.01.12.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABSIAbsci 3.00Buy$8.40169.23% UpsideNRCNational Research 0.00N/AN/AN/ARSSSResearch Solutions 0.00N/AN/AN/ATRAKReposiTrak 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RSSS, NRC, TRAK, and ABSI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/3/2025ABSIAbsciMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$7.005/14/2025ABSIAbsciNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.00(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABSIAbsci$4.53M87.86N/AN/A$1.56 per share2.00NRCNational Research$143.06M2.26$1.33 per share10.66$1.36 per share10.46RSSSResearch Solutions$48.75M1.80$0.01 per share304.76$0.36 per share7.50TRAKReposiTrak$20.45M16.49$0.40 per share46.52$2.57 per share7.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABSIAbsci-$103.11M-$0.92N/AN/AN/A-2,232.13%-53.69%-45.89%8/13/2025 (Estimated)NRCNational Research$24.78M$1.0313.81∞N/A17.14%71.33%18.67%7/28/2025 (Estimated)RSSSResearch Solutions-$3.79M-$0.14N/A45.003.00-8.03%-5.80%-1.59%9/18/2025 (Estimated)TRAKReposiTrak$5.96M$0.3454.27∞N/A30.13%13.89%12.44%N/ALatest RSSS, NRC, TRAK, and ABSI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025ABSIAbsci-$0.19N/AN/AN/A$1.39 millionN/A5/13/2025Q1 2025ABSIAbsci-$0.23-$0.21+$0.02-$0.21$1.07 million$1.18 million4/28/2025Q1 2025NRCNational ResearchN/A$0.25N/A$0.25N/A$33.55 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABSIAbsciN/AN/AN/AN/AN/ANRCNational Research$0.483.38%N/A46.60%N/ARSSSResearch SolutionsN/AN/AN/AN/AN/ATRAKReposiTrak$0.070.38%N/A20.59%2 YearsLatest RSSS, NRC, TRAK, and ABSI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/5/2025TRAKReposiTrakquarterly$0.020.37%9/30/20259/30/202511/14/20256/20/2025TRAKReposiTrakquarterly$0.01820.36%6/30/20256/30/20258/14/20254/25/2025NRCNational Researchquarterly$0.124.1%6/27/20256/27/20257/11/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABSIAbsciN/A5.725.72NRCNational Research1.980.540.54RSSSResearch SolutionsN/A0.760.76TRAKReposiTrak0.016.036.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABSIAbsci52.05%NRCNational Research47.26%RSSSResearch Solutions33.60%TRAKReposiTrak27.35%Insider OwnershipCompanyInsider OwnershipABSIAbsci10.49%NRCNational Research8.10%RSSSResearch Solutions12.90%TRAKReposiTrak44.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABSIAbsci210127.56 million114.18 millionOptionableNRCNational Research49022.78 million20.94 millionOptionableRSSSResearch Solutions13032.46 million28.27 millionNot OptionableTRAKReposiTrak7018.28 million10.24 millionN/ARSSS, NRC, TRAK, and ABSI HeadlinesRecent News About These CompaniesRandall K Fields Implements A Sell Strategy: Offloads $140K In ReposiTrak StockJuly 17 at 12:28 AM | benzinga.comRandall K. Fields Sells 1,500 Shares of ReposiTrak Inc. (NYSE:TRAK) StockJuly 17 at 6:53 AM | insidertrades.comInsider Selling: ReposiTrak Inc. (NYSE:TRAK) CEO Sells 1,500 Shares of StockJuly 16, 2025 | marketbeat.comReposiTrak Inc. (NYSE:TRAK) CEO Randall K. Fields Sells 4,500 SharesJuly 16, 2025 | marketbeat.comReposiTrak List Expands, Announcing 20 Specialty, Meat Snack and Plant-based Suppliers This WeekJuly 16, 2025 | businesswire.com6TRAK : Randall K Fields Implements A Sell Strategy: Offloads $147...July 9, 2025 | benzinga.comReposiTrak, Inc.'s (NYSE:TRAK) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?July 9, 2025 | finance.yahoo.comReposiTrak Inc. (NYSE:TRAK) CEO Sells $39,700.00 in StockJuly 9, 2025 | insidertrades.com31 Cheese Suppliers Join the ReposiTrak Queue for Food TraceabilityJuly 8, 2025 | finance.yahoo.comInsider Selling: ReposiTrak Inc. (NYSE:TRAK) CEO Sells 2,000 Shares of StockJuly 8, 2025 | marketbeat.comInsider Selling: ReposiTrak Inc. (NYSE:TRAK) CEO Sells 5,500 Shares of StockJuly 8, 2025 | marketbeat.comRandall K. Fields Sells 2,626 Shares of ReposiTrak Inc. (NYSE:TRAK) StockJuly 3, 2025 | insidertrades.comInsider Decision: Randall K Fields Offloads $147K Worth Of ReposiTrak StockJuly 2, 2025 | benzinga.comReposiTrak Inc. (NYSE:TRAK) CEO Randall K. Fields Sells 2,626 SharesJuly 2, 2025 | marketbeat.comReposiTrak Inc. (NYSE:TRAK) CEO Sells $94,799.30 in StockJuly 2, 2025 | marketbeat.comInsider Selling: Randall K Fields Unloads $146K Of ReposiTrak StockJune 26, 2025 | benzinga.comReposiTrak Inc. (NYSE:TRAK) CEO Sells $38,880.00 in StockJune 25, 2025 | marketbeat.comReposiTrak Inc. (NYSE:TRAK) CEO Randall K. Fields Sells 2,500 SharesJune 25, 2025 | marketbeat.comInsider Selling: ReposiTrak Inc. (NYSE:TRAK) CEO Sells 3,000 Shares of StockJune 25, 2025 | marketbeat.comReposiTrak Adds 40 New Egg and Dairy Suppliers to the Queue for the Rapidly Expanding Food Traceability NetworkJune 24, 2025 | tmcnet.comReposiTrak Inc. (NYSE:TRAK) Announces Quarterly Dividend of $0.02June 20, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRSSS, NRC, TRAK, and ABSI Company DescriptionsAbsci NASDAQ:ABSI$3.12 +0.24 (+8.33%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$3.14 +0.01 (+0.48%) As of 07/18/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.National Research NASDAQ:NRC$14.22 -0.73 (-4.88%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$14.37 +0.15 (+1.08%) As of 07/18/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.Research Solutions NASDAQ:RSSS$2.70 0.00 (0.00%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$2.70 0.00 (0.00%) As of 07/18/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Research Solutions, Inc., through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets. The company also offers Article Galaxy, a solution that allows research organizations to load their entitlements, consisting of subscriptions, discount or token packages, and their existing library of articles. In addition, it provides Manage platform, a references solution that allows users to access the article inside the platform including setting up personal folders or team folders and allows researchers to markup and take notes on the articles in a supported browser on a desktop or tablet. Further, the company's platform facilitates the sale of published STM content sold as individual articles. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was incorporated in 2006 and is based in Henderson, Nevada.ReposiTrak NYSE:TRAK$18.45 -0.25 (-1.34%) As of 07/18/2025 03:59 PM EasternPark City Group, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also provides ScoreTracker, Vendor Managed Inventory, Store Level Ordering and Replenishment, Enterprise Supply Chain Planning, Fresh Market Manager, and ActionManager supply chain solutions to manage inventory, product mix, and labor. In addition, the company offers business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, as well as professional consulting services. It primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. The company is headquartered in Murray, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
